Find Clinical Trial

Home » Find Clinical Trials » Evaluation of the effects of oral administration of ivabradine 5 mg and 7.5 mg b.i.d. in patients with heart failure and arterial hypertension insufficiently controlled by oral perindopril 4 mg per day. An open-label multicentre study.

Evaluation of the effects of oral administration of ivabradine 5 mg and 7.5 mg b.i.d. in patients with heart failure and arterial hypertension insufficiently controlled by oral perindopril 4 mg per day. An open-label multicentre study.

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Heart failure

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	IVABRADINE, S016257

Active Substance Code	S016257

Protocol Code	CL2-16257-073

EudraCT Code	2006-005886-21

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.